- Home
- AKRO vs UPST Comparison
AKRO vs UPST Comparison
Compare AKRO & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- UPST
- Stock Information
- Founded
- AKRO 2017
- UPST 2012
- Country
- AKRO United States
- UPST United States
- Employees
- AKRO N/A
- UPST N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- UPST Finance: Consumer Services
- Sector
- AKRO Health Care
- UPST Finance
- Exchange
- AKRO Nasdaq
- UPST Nasdaq
- Market Cap
- AKRO 4.5B
- UPST 3.8B
- IPO Year
- AKRO 2019
- UPST 2020
- Fundamental
- Price
- AKRO $54.34
- UPST $38.11
- Analyst Decision
- AKRO Buy
- UPST Buy
- Analyst Count
- AKRO 10
- UPST 15
- Target Price
- AKRO $73.56
- UPST $63.18
- AVG Volume (30 Days)
- AKRO 1.7M
- UPST 7.6M
- Earning Date
- AKRO 11-07-2025
- UPST 11-04-2025
- Dividend Yield
- AKRO N/A
- UPST N/A
- EPS Growth
- AKRO N/A
- UPST N/A
- EPS
- AKRO N/A
- UPST 0.26
- Revenue
- AKRO N/A
- UPST $997,748,000.00
- Revenue This Year
- AKRO N/A
- UPST $59.09
- Revenue Next Year
- AKRO N/A
- UPST $27.21
- P/E Ratio
- AKRO N/A
- UPST $140.59
- Revenue Growth
- AKRO N/A
- UPST 64.93
- 52 Week Low
- AKRO $21.34
- UPST $31.40
- 52 Week High
- AKRO $58.40
- UPST $96.43
- Technical
- Relative Strength Index (RSI)
- AKRO 68.92
- UPST 34.87
- Support Level
- AKRO $54.10
- UPST $36.67
- Resistance Level
- AKRO $54.37
- UPST $39.90
- Average True Range (ATR)
- AKRO 0.18
- UPST 2.39
- MACD
- AKRO -0.22
- UPST -0.21
- Stochastic Oscillator
- AKRO 89.00
- UPST 19.23
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.